A detailed history of Susquehanna Fundamental Investments, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 15,400 shares of HRMY stock, worth $527,912. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,400
Holding current value
$527,912
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$28.81 - $33.01 $443,674 - $508,353
15,400 New
15,400 $465 Million
Q1 2023

May 16, 2023

SELL
$30.8 - $53.92 $710,186 - $1.24 Million
-23,058 Reduced 63.78%
13,094 $427,000
Q4 2022

Feb 14, 2023

SELL
$45.4 - $60.91 $245,069 - $328,792
-5,398 Reduced 12.99%
36,152 $1.99 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $1.75 Million - $2.3 Million
41,550 New
41,550 $1.84 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.03B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.